ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bearish•Quantitative Analysis
•26 Jun 2026 08:10

ASX Short Interest Weekly (Jun 19th): Aristocrat Leisure, Brambles, CSL, Regis Resources, Cochlear

We analyzed ASX short interest report for the past week and highlight short interest changes in Aristocrat Leisure, Brambles, CSL, Regis Resources,...

Logo
101 Views
Share
bullish•Tencent
•29 May 2020 14:48

COVID-19 and ESG: Tencent, Alibaba Lead in Coronavirus Aid for Asia Pacific Region

"Social" has been a third-wheel ESG pillar for a long time. Not that it matters any less, and there is plenty of evidence that strong Social-pillar...

Logo
855 Views
Share
bearish•MSCI ACWI Index
•27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
634 Views
Share
•19 Oct 2019 10:51

Aussie Equities Model Portfolio Update (October): Sticking to the Knitting

Our model portfolio has added 200bp of Alpha since our last update and our stock selection remains broadly unchanged.  However, we make some key...

Logo
512 Views
Share
•30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
734 Views
Share
x